TY - JOUR AU - Cohen, Brian AU - Marshall, M. Blair PY - 2018 TI - Neoadjuvant PD-1 blockade in lung cancer: we’re not in Kansas anymore JF - Journal of Thoracic Disease; Vol 10, No 8 (August 29, 2018): Journal of Thoracic Disease Y2 - 2018 KW - N2 - In the May 24 th , 2018 issue of The New England Journal of Medicine , Patrick Forde and colleagues published a pilot study which examined the safety and feasibility of immune therapy to block programmed death 1 (PD-1) proteins by administering neo-adjuvant PD-1 Inhibitor in the setting of resectable non-small cell lung cancer (NSCLC) (1). In addition to demonstrating a lack of serious adverse events or surgical delay, they were also able to reveal a major pathologic response in tumor burden and provide greater insight into the dynamics of any anti-tumor immune response. UR - https://jtd.amegroups.org/article/view/22909